Picture of Stablecoin Development logo

SDEV Stablecoin Development News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsSpeculativeMicro CapValue Trap

Brief: NovaBay Pharma Reports Q2 2021 Financial Results

Aug 12 (Reuters) - NovaBay Pharmaceuticals Inc  NBY.A :
    * NOVABAY PHARMACEUTICALS REPORTS SECOND QUARTER 2021
FINANCIAL
RESULTS
    * Q2 LOSS PER SHARE $0.04

Source text for Eikon:  ID:nBw7JVyDra 
Further company coverage:  NBY.A 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Stablecoin Development

See all news